查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1939192

2026年全球急性護理症候群診斷市場報告

Acute Care Syndromic Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，急性護理中的症候群檢測市場規模迅速擴大，預計將以 12.8% 的複合年成長率成長，從 2025 年的 45.9 億美元成長到 2026 年的 51.7 億美元。過去幾年成長要素包括對緊急感染疾病診斷的需求、醫院加護病房的擴建、感染疾病防範工作、分子診斷技術的應用以及重症監護工作流程的最佳化。

預計未來幾年，急性症候群檢測市場將快速成長，到2030年市場規模將達到83億美元，複合年成長率（CAGR）為12.5%。預測期內的成長要素包括人工智慧賦能的症候群檢測、急診檢測的擴展、抗菌藥物管理計劃、照護現場分子診斷系統以及對疫情防範的重視。預測期內的關鍵趨勢包括快速多病原體檢測、急診室的分子檢測、單檢體多疾病檢測、更快的臨床決策支援以及更快的診斷結果週轉時間。

感染疾病率的上升預計將推動急性護理機構中綜合症檢測市場的成長。由細菌、病毒、真菌和寄生蟲等有害微生物引起的感染疾病可透過人際接觸、動物和環境傳播。人口成長、都市化、國際旅行、抗菌素抗藥性和氣候變遷等因素導致這些疾病的發病率上升，從而推動了對有效診斷和治療方案的需求。急性期綜合症檢測透過多重分子診斷技術在識別病原體和合併感染方面發揮關鍵作用，從而實現精準治療決策。例如，根據英國衛生安全執行局2024年2月發布的報告，2024年第4週的流感陽性率從前一周的14.0%上升至16.6%。流感樣疾病（ILI）就診人數也有所增加，從前一週的每10萬人7.5人增加到9.8人。同時，流感相關住院人數從前一週的每10萬人有5.12人上升至7.63人。因此，感染疾病的上升趨勢正在推動急性症候群檢測市場的擴張。

急性症候群檢測市場的主要企業正利用多重即時聚合酵素鏈鎖反應(PCR) 技術的進步來提高診斷準確性、實現病原體快速檢測、簡化檢查室工作流程並縮短檢測結果報告時間。多重即時PCR是一種先進的分子診斷方法，可在單次反應中同時檢測和定量多種病原體或基因標靶，從而提高疾病診斷的效率和準確性。 2023 年 4 月，總部位於荷蘭的生物技術公司 QIAGEN NV 在日本推出了 QIAstat-Dx 症候群檢測解決方案。該系統配備了 SARS-CoV-2 呼吸道病原體檢測板，能夠從單一檢體中檢測 20 多種病原體。與傳統 PCR 檢測相比，該系統利用多重即時PCR技術，能夠以最少的人力快速獲得檢測結果。截至 2022 年底，全球已安裝超過 3500 套 QIAstat-Dx 系統，用於支持呼吸道疾病、胃腸道疾病和腦膜炎相關疾病的診斷。該系統已在 100 多個國家/地區投入使用，有助於提高全球對症候群檢測的可及性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球急性護理綜合症診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 快速多重病原體檢測
    • 急診室的分子檢測
    • 單檢體多病種檢測
    • 加速臨床決策支持
    • 縮短診斷結果等待時間

第5章 終端用戶產業市場分析

  • 醫院
  • 急診室
  • 臨床檢查室
  • 加護病房
  • 公共衛生實驗室

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球急性照護症候群診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球急性護理症候群診斷市場規模、對比及成長率分析
  • 全球急性照護症候群診斷市場表現：規模與成長，2020-2025年
  • 全球急性照護症候群診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依疾病類型
  • 呼吸系統疾病、消化系統疾病、泌尿生殖系統疾病、熱帶疾病等疾病類型
  • 依檢體類型
  • 血液、尿液、體液、糞便、拭子和其他檢體
  • 按目標
  • 細菌、病毒、真菌、寄生蟲
  • 最終用戶
  • 醫院、臨床檢查室、研究和學術機構以及其他最終用戶
  • 按類型細分：呼吸系統疾病
  • 流感、呼吸道融合細胞病毒（RSV）、新冠病毒、結核病和其他呼吸道疾病
  • 按類型細分：胃腸道疾病
  • 困難梭狀芽孢桿菌傳染病、諾羅病毒、輪狀病毒、沙門氏菌和其他胃腸道疾病
  • 依類型細分：泌尿生殖系統疾病
  • 尿道感染（UTI）、性行為感染感染（STI）、陰道感染疾病和其他泌尿生殖系統疾病
  • 按類型細分：熱帶疾病
  • 瘧疾、登革熱、屈公病、茲卡病毒和其他熱帶疾病
  • 按類型細分：其他疾病類型
  • 腦膜炎、敗血症和其他新興感染疾病

第10章 區域與國家分析

  • 全球急性照護症候群診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球急性照護症候群診斷市場：國家、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 急性護理症候群診斷市場：競爭格局與市場佔有率，2024 年
  • 急性照護症候群診斷市場：公司估值矩陣
  • 急性護理綜合症診斷市場：公司簡介
    • Siemens Healthineers AG
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company

第37章：其他領先和創新企業

  • Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Werfen, DiaSorin SpA, Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年急性照護症候群診斷市場：提供新機會的國家
  • 2030年急性照護症候群診斷市場：提供新機會的細分市場
  • 2030年急性照護症候群診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MACST01_G26Q1

Acute care syndromic testing is a rapid molecular diagnostic approach that detects multiple pathogens simultaneously from a single patient sample. Primarily used in emergency and critical care settings, it enables quicker diagnosis of infectious diseases, leading to faster treatment decisions, improved patient outcomes, and reduced hospital stays.

The main disease types in the acute care syndromic testing market include respiratory diseases, gastrointestinal diseases, genitourinary diseases, tropical diseases, and others. Respiratory diseases affect the lungs, airways, and respiratory tract, causing symptoms such as coughing, shortness of breath, and fever. Various sample types used for testing include blood, urine, biofluids, stool, swabs, and more. The tests target bacteria, viruses, fungi, and parasites and are utilized in hospitals, clinical and diagnostic laboratories, research and academic institutions, and other healthcare settings.

Tariffs have increased costs of reagents, cartridges, and molecular testing platforms in the acute care syndromic testing market. Respiratory and gastrointestinal panels are most affected, particularly in regions reliant on imported diagnostics. However, tariffs have accelerated local manufacturing and innovation in compact, cost-efficient testing systems.

The acute care syndromic testing market research report is one of a series of new reports from The Business Research Company that provides acute care syndromic testing market statistics, including acute care syndromic testing industry global market size, regional shares, competitors with a acute care syndromic testing market share, detailed acute care syndromic testing market segments, market trends and opportunities, and any further data you may need to thrive in the acute care syndromic testing industry. This acute care syndromic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute care syndromic testing market size has grown rapidly in recent years. It will grow from $4.59 billion in 2025 to $5.17 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to emergency infection diagnosis demand, hospital ICU expansion, outbreak preparedness initiatives, molecular diagnostic adoption, critical care workflow optimization.

The acute care syndromic testing market size is expected to see rapid growth in the next few years. It will grow to $8.3 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to AI-enabled syndromic panels, expansion of emergency testing, antimicrobial stewardship programs, point-of-care molecular systems, pandemic preparedness focus. Major trends in the forecast period include rapid multiplex pathogen detection, emergency department molecular testing, single-sample multi-disease panels, faster clinical decision support, reduced diagnostic turnaround time.

The increasing prevalence of infectious diseases is expected to drive the growth of the acute care syndromic testing market. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread through human contact, animals, or the environment. Factors such as population growth, urbanization, global travel, antimicrobial resistance, and climate change are contributing to the rising incidence of these diseases, increasing the demand for effective diagnostic and treatment solutions. Acute care syndromic testing plays a crucial role in identifying pathogens and co-infections through multiplex molecular diagnostics, allowing for targeted treatment decisions. For example, in February 2024, the UK Health Security Agency reported that in week 4 of 2024, the influenza positivity rate rose to 16.6%, up from 14.0% the previous week. Influenza-like illness (ILI) consultations also increased, reaching 9.8 per 100,000 people compared to 7.5 per 100,000 in the prior week, while influenza hospitalizations climbed from 5.12 to 7.63 per 100,000. Consequently, the growing incidence of infectious diseases is fueling the expansion of the acute care syndromic testing market.

Leading companies in the acute care syndromic testing market are leveraging advancements in multiplex real-time polymerase chain reaction (PCR) technology to enhance diagnostic accuracy, enable rapid pathogen detection, streamline laboratory workflows, and reduce turnaround time. Multiplex real-time PCR is an advanced molecular diagnostic method that simultaneously detects and quantifies multiple pathogens or genetic targets in a single reaction, improving efficiency and accuracy in disease diagnosis. In April 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the QIAstat-Dx syndromic testing solution in Japan. This system features a SARS-CoV-2 respiratory panel capable of detecting over 20 pathogens from a single sample. Using multiplex real-time PCR technology, it provides rapid results with minimal labor compared to traditional PCR assays. By the end of 2022, over 3,500 QIAstat-Dx systems had been installed worldwide, aiding in the diagnosis of respiratory, gastrointestinal, and meningitis-related conditions. Available in more than 100 countries, this system is improving global access to syndromic testing.

In May 2023, Applied BioCode, a US-based biotechnology company, partnered with Medline Industries to expand the distribution of the BioCode MDx-3000 System. This collaboration aims to enhance access to diagnostic testing for hospitals and reference laboratories across the U.S. Medline Industries LP, a US-based healthcare company specializing in medical supplies and healthcare services, will support the distribution of Applied BioCode's multiplex diagnostic solutions, further advancing syndromic testing capabilities.

Major companies operating in the acute care syndromic testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

North America was the largest region in the acute care syndromic testing market in 2025. The regions covered in the acute care syndromic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute care syndromic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The acute care syndromic testing market consists of revenues earned by entities by providing services such as comprehensive pathogen detection, rapid turnaround time, and support for antimicrobial stewardship. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute care syndromic testing market also includes sales of blood collection tubes, or urine containers, PCR and RT-PCR machines, and reader devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Care Syndromic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses acute care syndromic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute care syndromic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute care syndromic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Disease Type: Respiratory Diseases; Gastrointestinal Diseases; Genitourinary Diseases; Tropical Diseases; Other Disease Types
  • 2) By Sample Type: Blood; Urine; Biofluids; Stool; Swabs; Other Sample Types
  • 3) By Target: Bacteria; Viruses; Fungi; Parasites
  • 4) By End User: Hospitals; Clinical And Diagnostic Laboratories; Research And Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Respiratory Diseases: Influenza; Respiratory Syncytial Virus (RSV); COVID-19; Tuberculosis; Other Respiratory Diseases
  • 2) By Gastrointestinal Diseases: Clostridium Difficile Infection; Norovirus; Rotavirus; Salmonella; Other Gastrointestinal Diseases
  • 3) By Genitourinary Diseases: Urinary Tract Infections (UTIs); Sexually Transmitted Infections (STIs); Vaginal Infections; Other Genitourinary Diseases
  • 4) By Tropical Diseases: Malaria; Dengue; Chikungunya; Zika Virus; Other Tropical Diseases
  • 5) By Other Disease Types: Meningitis; Sepsis; Other Emerging Infectious Diseases
  • Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Seegene Inc.; bioMerieux SA; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Werfen; DiaSorin S.p.A.; Quidel Corporation; Luminex Corporation; Biocartis NV; Microbiologics Inc.; QuantuMDx Group Ltd.; Curetis GmbH by OpGen Inc.; Genetic Signatures Ltd.; Applied BioCode Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Acute Care Syndromic Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Acute Care Syndromic Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Acute Care Syndromic Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Acute Care Syndromic Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rapid Multiplex Pathogen Detection
    • 4.2.2 Emergency Department Molecular Testing
    • 4.2.3 Single-Sample Multi-Disease Panels
    • 4.2.4 Faster Clinical Decision Support
    • 4.2.5 Reduced Diagnostic Turnaround Time

5. Acute Care Syndromic Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Emergency Care Units
  • 5.3 Clinical Diagnostic Laboratories
  • 5.4 Intensive Care Units
  • 5.5 Public Health Laboratories

6. Acute Care Syndromic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Acute Care Syndromic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Acute Care Syndromic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Acute Care Syndromic Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Acute Care Syndromic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Acute Care Syndromic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Acute Care Syndromic Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Acute Care Syndromic Testing Market Segmentation

  • 9.1. Global Acute Care Syndromic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Respiratory Diseases, Gastrointestinal Diseases, Genitourinary Diseases, Tropical Diseases, Other Disease Types
  • 9.2. Global Acute Care Syndromic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Urine, Biofluids, Stool, Swabs, Other Sample Types
  • 9.3. Global Acute Care Syndromic Testing Market, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bacteria, Viruses, Fungi, Parasites
  • 9.4. Global Acute Care Syndromic Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical And Diagnostic Laboratories, Research And Academic Institutions, Other End Users
  • 9.5. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Respiratory Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Influenza, Respiratory Syncytial Virus (RSV), COVID-19, Tuberculosis, Other Respiratory Diseases
  • 9.6. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Gastrointestinal Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clostridium Difficile Infection, Norovirus, Rotavirus, Salmonella, Other Gastrointestinal Diseases
  • 9.7. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Genitourinary Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Urinary Tract Infections (UTIs), Sexually Transmitted Infections (STIs), Vaginal Infections, Other Genitourinary Diseases
  • 9.8. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Tropical Diseases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Malaria, Dengue, Chikungunya, Zika Virus, Other Tropical Diseases
  • 9.9. Global Acute Care Syndromic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Meningitis, Sepsis, Other Emerging Infectious Diseases

10. Acute Care Syndromic Testing Market Regional And Country Analysis

  • 10.1. Global Acute Care Syndromic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Acute Care Syndromic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Acute Care Syndromic Testing Market

  • 11.1. Asia-Pacific Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Acute Care Syndromic Testing Market

  • 12.1. China Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Acute Care Syndromic Testing Market

  • 13.1. India Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Acute Care Syndromic Testing Market

  • 14.1. Japan Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Acute Care Syndromic Testing Market

  • 15.1. Australia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Acute Care Syndromic Testing Market

  • 16.1. Indonesia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Acute Care Syndromic Testing Market

  • 17.1. South Korea Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Acute Care Syndromic Testing Market

  • 18.1. Taiwan Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Acute Care Syndromic Testing Market

  • 19.1. South East Asia Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Acute Care Syndromic Testing Market

  • 20.1. Western Europe Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Acute Care Syndromic Testing Market

  • 21.1. UK Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Acute Care Syndromic Testing Market

  • 22.1. Germany Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Acute Care Syndromic Testing Market

  • 23.1. France Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Acute Care Syndromic Testing Market

  • 24.1. Italy Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Acute Care Syndromic Testing Market

  • 25.1. Spain Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Acute Care Syndromic Testing Market

  • 26.1. Eastern Europe Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Acute Care Syndromic Testing Market

  • 27.1. Russia Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Acute Care Syndromic Testing Market

  • 28.1. North America Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Acute Care Syndromic Testing Market

  • 29.1. USA Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Acute Care Syndromic Testing Market

  • 30.1. Canada Acute Care Syndromic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Acute Care Syndromic Testing Market

  • 31.1. South America Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Acute Care Syndromic Testing Market

  • 32.1. Brazil Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Acute Care Syndromic Testing Market

  • 33.1. Middle East Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Acute Care Syndromic Testing Market

  • 34.1. Africa Acute Care Syndromic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Acute Care Syndromic Testing Market, Segmentation By Disease Type, Segmentation By Sample Type, Segmentation By Target, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Acute Care Syndromic Testing Market Regulatory and Investment Landscape

36. Acute Care Syndromic Testing Market Competitive Landscape And Company Profiles

  • 36.1. Acute Care Syndromic Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Acute Care Syndromic Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Acute Care Syndromic Testing Market Company Profiles
    • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Acute Care Syndromic Testing Market Other Major And Innovative Companies

  • Seegene Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Werfen, DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Biocartis NV, Microbiologics Inc., QuantuMDx Group Ltd., Curetis GmbH by OpGen Inc., Genetic Signatures Ltd., Applied BioCode Inc.

38. Global Acute Care Syndromic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Acute Care Syndromic Testing Market

40. Acute Care Syndromic Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Acute Care Syndromic Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Acute Care Syndromic Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Acute Care Syndromic Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer